Status:
UNKNOWN
Type 1 Diabetes Prediction and Prevention (DIPP) Study
Lead Sponsor:
Riitta Veijola
Collaborating Sponsors:
Oulu University Hospital
University of Turku
Conditions:
Type 1 Diabetes Mellitus
Eligibility:
All Genders
Brief Summary
The Type 1 Diabetes Prediction and Prevention (DIPP) Study in Finland is a population-based long-term clinical follow-up study established since 1994 in three university hospitals in Finland to unders...
Detailed Description
Briefly, cord blood samples are collected and HLA-DR-DQ genotypes are determined from newborn babies. Families with a newborn baby carrying a DR-DQ genotype associated with increased risk for T1D are ...
Eligibility Criteria
Inclusion
- Newborn babies with HLA-conferred genetic susceptibility to type 1 diabetes born in three University Hospitals in Finland
Exclusion
- Newborn babies without HLA-conferred genetic susceptibility to type 1 diabetes
Key Trial Info
Start Date :
November 7 1994
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
17000 Patients enrolled
Trial Details
Trial ID
NCT03269084
Start Date
November 7 1994
End Date
December 31 2024
Last Update
April 7 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Oulu and Oulu University Hospital
Oulu, Finland, 90029
2
University of Tampere and Tampere University Hospital
Tampere, Finland, 33520
3
University of Turku and Turku University Hospital
Turku, Finland, 20520